1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A standard operating procedure for the curation of gene fusions
    Meeting Abstract

    Wagner, A. H.; Vlachos, I. S.; Sonkin, D.; Terraf, P.; Kesserwan, C.; Sboner, A.; Coard, T.; Reich, C.; Ritter, D. I.; Horak, P.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • IMmotion151: Updated overall survival (OS) and exploratory analysis of the association of gene expression and clinical outcomes with atezolizumab plus bevacizumab vs sunitinib in patients with locally advanced or metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Rini, B. I.; Atkins, M. B.; Escudier, B.; Powles, T.; McDermott, D. F.; Alekseev, B. Y.; Lee, J. L.; Stroyakovskiy, D.; Suarez Rodriguez, C.; De Giorgi, U.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase 3 randomized trial comparing tebentafusp with investigator's choice in first line metastatic uveal melanoma
    Meeting Abstract

    Piperno-Neumann, S.; Hassel, J. C.; Rutkowski, P.; Baurain, J. F.; Butler, M. O.; Schlaak, M.; Sullivan, R. J.; Ochsenreither, S.; Dummer, R.; Kirkwood, J. M.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Large-scale genome-wide association study identifies multiple novel germline susceptibility variants associated with bladder cancer risk
    Meeting Abstract

    Koutros, S.; Kiemeney, L. A.; Milne, R. L.; Ye, Y.; Joseph, V.; Figueroa, J.; Chatterjee, N.; Giles, G. G.; Hildebrandt, M. A.; Dyrskjot, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers
    Meeting Abstract

    Subbiah, V.; Konda, B.; Bauer, T.; McCoach, C.; Falchook, G.; Takeda, M.; Patel, J.; Weiss, J.; Peled, N.; Bazhenova, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Pooled analysis of drug-related interstitial lung disease (ILD) in 8 single-arm trastuzumab deruxtecan (T-DXd) studies
    Meeting Abstract

    Powell, C. A.; Modi, S.; Iwata, H.; Takahashi, S.; Smit, E. F.; Siena, S.; Chang, D. Y.; Fuchs, C. S.; Nie, K.; Qin, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Master protocol to assess the safety and recommended Phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and non-small cell lung cancer
    Meeting Abstract

    Schoenfeld, A. J.; Altan, M.; Owonikoko, T. K.; D'Angelo, S.; Ladle, B. H.; Noujaim, J.; He, K.; Liebner, D.; Sacher, A. G.; Haanen, J. B. A. G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • HSF1 promotes inflammation induced tumor development through ECM remodeling
    Meeting Abstract

    Galibov, O. L.; Lavon, H.; Wassermann-Dozorets, R.; Pevsner-Fischer, M.; Mayer, S.; Wershof, E.; Stein, Y.; Brown, L. E.; Zhang, W.; Friedman, G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Addition of parsaclisib (INCB050465), a PI3Kδ inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis
    Meeting Abstract

    Yacoub, A.; Wang, E. S.; Rampal, R. K.; Borate, U.; Kremyanskaya, M.; Ali, H.; Hobbs, G. S.; O'Connell, C.; Assad, A.; Erickson-Viitanen, S.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Transcriptome-wide association study of endometrial cancer risk
    Meeting Abstract

    Zhu, J.; O'Mara, T. A.; Setiawan, V. W.; Du, M. M.; ECAC consortium; Friedenreich, C.; Cook, L. S.; Lacey, J.; Chen, C.; Johnson, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save